Les dernières années ont donné naissance à un certain nombre de découvertes et d'avancées enthousiasmantes pour le diagnostic, le traitement et le soin des patients en oncologie. Selon les diverses sources, il existe environ 1,800 molécules en oncologie à divers stades de développement dans les pépinières des sociétés pharmaceutiques. Nous nous attendons donc à connaître une importante explosion dans le marché des molécules au cours de la prochaine décennie. Si nous associons cette explosion à l’accroissement aussi attendu de la participation des omnipraticiens à la prise en charge des patients d'oncologie, nous constatons que l'industrie devra redéployer des représentants dans le milieu de l'oncologie.

Ce cours et le cours d'Oncologie II de l'université McGill sont nécessaires pour obtenir le certificat en Oncologie. Suivre ce lien pour le cours d'Oncologie II. Vous pouvez vous inscrire aux deux cours en même temps mais prenez note que le cours d'Oncologie I est un prérequis pour le cours II.

Ce nouveau cours du CFPC représente une nouveauté par rapport à l'ancienne formule de cours en format papier. Par exemple :

  • ce cours est entièrement administré en ligne; son contenu et ses examens sont tous livrés par le système de gestion de l'apprentissage du CFPC. (Les étudiants qui sont familiers avec les cours du CFPC reconnaîtront le système de gestion de l'apprentissage qu'ils utilisaient lors des examens en ligne);
  • chaque module du cours a son propre examen. Cette formule favorise l'apprentissage de la matière pertinente à l'examen, la réussite de l'examen et le passage au module suivant. (Elle réduit la quantité de notions à étudier à la fois et élimine le stress d'avoir à réussir un « gros examen » à la fin du cours);
  • tous les examens se font en ligne et la note de chacun de ces examens contribue à la note globale du cours;
  • les étudiants inscrits à ce cours doivent réussir le cours Oncologie I (le présent cours) et le cours Oncologie II pour recevoir leur certificat en Oncologie; (la réussite des 2 cours est requise pour être admissible au prix et médailles du CFPC)
  • parmi les personnes qui suivent actuellement ce cours, mentionnons des médecins et autres professionnels de la santé, ainsi que des étudiants, des internes et des résidents en médecine de l'Université McGill. Vous suivrez donc le même cours qu'eux!
Onco
Détails du produit

Nom du cours
Oncologie I de l'université McGill (REMARQUE: cours offert en anglais seulement)

Contenu
9 modules d'apprentissage en ligne sur portail MonCFPC
Nombre d'heures d'étude: 60
Note: 6 mois compléter le programme au complet

REMARQUE: Cliquez sur les en-têtes ci-dessous pour plus de détails

Module 1: Introduction to cancer

Reviews basic concepts in oncology, the pathophysiology of cancer, its detection, diagnostic, treatment and epidemiology. After reading this module, you should be able to:
  1. Define cancer and explain the difference between benign and malignant tumors.
  2. Differentiate between carcinomas, sarcomas, leukemias and lymphomas.
  3. List the early warning signs of cancer.
  4. List potential uses for tumor markers.
  5. Describe the advantages and disadvantages of cancer screening in the cancer prevention process.
  6. Describe the role of various cancer treatments.

Module 2: Treatment of cancer

In this module, we begin with a discussion of the process of cancer drug development. This information will help in the interpretation of clinical outcomes of cancer clinical trials. Also discussed, are standardized tools used to assess toxicity and quality of life in patients receiving cancer therapies. Conventional antineoplastic drugs, hormonal and immune responses for cancer, and the major side effects of these therapies will be discussed as well. After reading this module, you should be able to:
  1. Explain the three steps of a new antineoplastic therapy.
  2. Compare and contrast the four clinical phases of cancer drug development.
  3. Discuss comparative measures of response, survival, toxicity and quality of life that may be used in cancer treatment trials.
  4. Explain the importance of pharmacoeconomics in cancer treatment decisions.
  5. Explain different cancer therapy methods.

Module 3: Lung cancer

Lung cancer is the leading cause of cancer mortality for both men and women, and is the only cancer with a clear preventable etiology. This module discusses the modern advances in the prevention of lung cancer, the pathology of the disease, as well as the diagnosis of lung cancer, its prognosis and treatment. After reading this module you should be able to:
  1. Describe the risks of smoking and the importance of primary prevention of lung cancer.
  2. Describe the importance of smoking cessation.
  3. Describe the current status of screening.
  4. Describe the signs and symptoms of lung cancer.
  5. Describe the methods involved in diagnosis and staging of lung cancer, and its prognosis and treatments.

Module 4: Colorectal cancer

Colorectal cancer is the fourth most common cancer in Canada and the second most frequent cause of death for cancers. In this module, we examine the risk factors, prevention, screening, and classification, as well as therapy for metastatic cancer, which are applicable to both colon cancer and rectal cancer; hence the term colorectal cancer. After reading this module, you should be able to:
  1. Describe the risk factors for developing colorectal cancer.
  2. Describe the screening tests for colorectal cancer.
  3. Describe the staging and prognosis for colorectal cancer.
  4. Describe the treatment and follow up for colorectal cancer.

Module 5: Head and Neck cancer

Head and neck cancer refers to a group of 7 malignancies originating in the upper aerodigestive tract. This module will not discuss thyroid or salivary gland malignancies. It will cover the different types of head and neck cancer, risk factors associated with the disease, signs and symptoms, and prognosis, treatment, screening and prevention. After reading this module, you should be able to:
  1. Identify the major types of head and neck cancer.
  2. Describe the risk factors for the development of head and neck cancer.
  3. Describe the signs and symptoms of head and neck cancer.
  4. Describe the treatment of head and neck cancer.
  5. Describe the screening and prevention of head and neck cancer.

Module 6: Lymphoma and Myeloma

Lymphoma, myeloma and leukemia are tumors of hematopoietic tissue. The two main types of lymphomas are Hodgkin's lymphoma and non-Hodgkin's lymphoma. Hodgkin's lymphoma is a relatively uncommon diagnosis. Non-Hodgkin's lymphoma is the fifth most common cancer diagnosis among Canadian men and women. The clinical severity/significance of myeloma is very variable, and ranges from a benign increased production/presence of a specific immunoglobulin subtype to a full blown multiple myeloma. After reading this module, you should be able to:
  1. Describe the characteristics of myeloma, Hodgkin's lymphoma and non-Hodgkin's lymphoma.
  2. Describe methods that can be used to detect myeloma, Hodgkin's lymphoma and non-Hodgkin's lymphoma.
  3. Describe the prognosis and treatment of Hodgkin's lymphoma and non-Hodgkin's lymphoma.
  4. Describe the goals of myeloma therapy.

Module 7: Breast cancer

Breast cancer is the most common malignancy found in women and the second most common cause of death from cancer in developed countries. This module will discuss the different types of breast cancer, the risk factors associated with the disease, its signs and symptoms, as well as the prognosis and treatment of breast cancer. Finally, this module will discuss various screening and prevention methods. After reading this module, you should be able to:
  1. Identify the major types of breast cancer.
  2. Describe the risk factors, signs and symptoms of breast cancer.
  3. Describe the prognosis and treatments of breast cancer.
  4. Describe methods that can be used to screen for and prevent breast cancer.

Module 8: Leukemia

Leukemia is characterized primarily but not exclusively by changes in the peripheral blood cells. In leukemia, neoplastic cells are present in the marrow and peripheral blood, and may also be present in the lymph nodes and other tissues. After reading this module, you should be able to:
  1. Describe the characteristics of acute leukemia, chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL).
  2. Describe their signs and symptoms.
  3. Describe their diagnosis and treatments methods.

Module 9: Palliative care

Palliative care is an approach that provides physical, psychosocial and spiritual care to patients and their families who are facing a life threatening illness. In this module, we discuss the philosophy of palliative care and the dying process, types of pain associated with cancer and agents used to provide symptomatic relief. We also discuss some common physical discomforts experienced by palliative care patients and the recommended treatments. After reading this module, you should be able to:
  1. Describe the philosophy of palliative care.
  2. Describe how pain is perceived.
  3. Describe the characteristics of acute and chronic cancer-related pain.
  4. Identify drugs used for treatment of nociceptive and neuropathic pain in patients with cancer.
  5. Describe the agents used for symptomatic relief of physical symptoms that may accompany cancer.

Unités É.C.
6 (qu'est-ce que c'est?)

Principaux objectifs

Après la fin du cours, les étudiants seront en mesure de:

  • Discuter de l'épidémiologie, de la détection, du diagnostic et du traitement des différents types de cancer
  • Discuter du traitement palliatif pour les patients en oncologie
Inscription

Inscrivez-vous à ce cours en utilisant notre formulaire d'inscription en ligne sécurisé

Prix:
1,238.00$
Entreprises affiliées: 619.00$
Entreprises non affiliées: 3,095.00$

Information
Pour plus de détails sur les méthodes de paiement, les frais de livraison et la politique de retour, suivre ce lien

Détails de l'examen

Type de questions
À choix multiples

Nombre de questions
9 examens individuels (pour un total de 99 questions à choix multiples)

Durée de l'examen
Variable, selon le module (de 10 à 30 minutes par module)

Note de passage
55%

test
help Vous voulez en savoir plus?
Nous contactez